Compare
Rallybio Corp vs Rafael Holdings, Inc. vs Onconetix, Inc. vs Shattuck Labs, Inc.
| Latest fiscal year | Rallybio Corp RLYB | Rafael Holdings, Inc. RFL | Onconetix, Inc. ONCO | Shattuck Labs, Inc. STTK |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-07-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $858.0K | $874.0K | $815.4K | $1.00M |
| Revenue growth (YoY) | +34.9% | -4.7% | -67.7% | -82.5% |
| Gross margin | n/a | n/a | 77.6% | n/a |
| Operating margin | n/m | n/m | n/m | n/m |
| Net margin | n/m | n/m | n/m | n/m |
| Net income | -$8.98M | -$29.64M | -$14.03M | -$48.81M |
| EPS (Diluted) | -$1.59 | -$0.58 | -$16.56 | -$0.70 |
| Operating cash flow | -$29.81M | -$29.99M | -$9.68M | -$39.88M |
| Free cash flow | n/a | -$29.99M | n/a | -$39.95M |
| Cash & equivalents | $31.37M | $22.10M | n/a | $54.19M |
| Total assets | $62.26M | $83.06M | $24.93M | $91.03M |
| Total liabilities | $4.30M | $11.09M | $9.16M | $8.64M |
| Shareholders' equity | $57.96M | $71.97M | $15.76M | $82.39M |
| Return on year-end equity | -15.5% | -41.2% | -89.0% | -59.2% |
| Shares outstanding | 5.28M | n/a | 1.56M | 63.28M |
Revenue, most recent five fiscal years
| Fiscal year | Rallybio Corp | Rafael Holdings, Inc. | Onconetix, Inc. | Shattuck Labs, Inc. |
|---|---|---|---|---|
| Latest | $858.0K Ended 2025-12-31 | $874.0K Ended 2026-07-31 | $815.4K Ended 2025-12-31 | $1.00M Ended 2025-12-31 |
| 1 year earlier | $636.0K Ended 2024-12-31 | $917.0K Ended 2025-07-31 | $2.52M Ended 2024-12-31 | $5.72M Ended 2024-12-31 |
| 2 years earlier | n/a | $637.0K Ended 2024-07-31 | $58.5K Ended 2023-12-31 | $1.66M Ended 2023-12-31 |
| 3 years earlier | n/a | $279.0K Ended 2023-07-31 | n/a | $652.0K Ended 2022-12-31 |
| 4 years earlier | n/a | $410.0K Ended 2022-07-31 | n/a | $30.02M Ended 2021-12-31 |